F
Fabien Zoulim
Researcher at French Institute of Health and Medical Research
Publications - 716
Citations - 40988
Fabien Zoulim is an academic researcher from French Institute of Health and Medical Research. The author has contributed to research in topics: Hepatitis B virus & Hepatitis B. The author has an hindex of 96, co-authored 641 publications receiving 35807 citations. Previous affiliations of Fabien Zoulim include Hotel Dieu Hospital & University of Orléans.
Papers
More filters
Journal ArticleDOI
The role of nucleoside and nucleotide analogues in nodular regenerative hyperplasia in HIV-infected patients: a case control study.
Laurent Cotte,Thomas Bénet,Claire Billioud,Patrick Miailhes,Jean-Yves Scoazec,Tristan Ferry,Corinne Brochier,André Boibieux,Philippe Vanhems,Michèle Chevallier,Fabien Zoulim,Fabien Zoulim +11 more
TL;DR: Nodular regenerative hyperplasia in HIV-infected patients seems strongly related to age and the cumulative exposure to didanosine+stavudine,didanosine, and stavuda, and to tenofovir.
Journal ArticleDOI
In Vitro Activity of 2,4-Diamino-6-[2-(Phosphonomethoxy)Ethoxy]-Pyrimidine against Multidrug-Resistant Hepatitis B Virus Mutants
Marie-Noëlle Brunelle,Julie Lucifora,Julie Lucifora,Johan Neyts,Stéphanie Villet,Stéphanie Villet,Antony Holy,Christian Trepo,Fabien Zoulim +8 more
TL;DR: Most drug-resistant mutants, including multidrug-resistant strains, remained sensitive to tenofovir and PMEO-DAPym, and the latter molecule deserves further evaluation for the treatment of HBV infection.
Journal ArticleDOI
Variable expression of preS1 antigen in serum during chronic hepatitis B virus infection: an accurate marker for the level of hepatitis B virus replication.
Marie-Anne Petit,Fabien Zoulim,Francis Caipel,Sylvie Dubanchet,Charles Dauguet,Christina Trepo +5 more
TL;DR: In chronic HBsAg carriers the serum expression of preSl antigen correlates well with the level of hepatitis B virus replication and that it may be useful in assessing the clinical importance of the chronic viral infection.
Journal ArticleDOI
Probability of HBsAg loss after nucleo(s)tide analogue withdrawal depends on HBV genotype and viral antigen levels.
Milan J. Sonneveld,Shao-Ming Chiu,Jynkyun Park,Sylvia M Brakenhoff,Apichat Kaewdech,Wai-Kay Seto,Ivana Carey,Margarita Papatheodoridi,Florian van Bömmel,Thomas Berg,Fabien Zoulim,Shin Ahn,Georgios N. Dalekos,N. Erler,Christoph Höner zu Siederdissen,Heiner Wedemeyer,Markus Cornberg,Man-Fung Yuen,Kosh Agarwal,Andre Boonstra,Maria Buti,Teerha Piratvisuth,George V. Papatheodoridis,Chung-Hwan Chen,Benjamin Maasoumy +24 more
TL;DR: In this paper , the authors studied predictors of HBsAg loss in a global cohort of HBeAg-negative patients with undetectable HBV DNA who discontinued long-term NUC therapy.
Journal ArticleDOI
Hepatitis C virus infection triggers a tumor‐like glutamine metabolism
Pierre L. Lévy,Sarah Duponchel,Hannah Eischeid,Jennifer Molle,Maud Michelet,Gaeelle Diserens,Martina Vermathen,Peter Vermathen,Jean-François Dufour,Hans-Peter Dienes,Hans-Peter Dienes,Hans-Michael Steffen,Margarete Odenthal,Fabien Zoulim,Birke Bartosch +14 more
TL;DR: The data suggest that HCV establishes glutamine dependence, which is required for viral replication, and, importantly, that glutamine addiction is a hallmark of tumor cells.